2014International journal of pediatricsRequires access

Application progress of immunosuppresive agent in refractory nephritic syndrome in children

Qiaohuan Yang

Open publisher page 0 citations

Abstract

Refractory nephrotic syndrome(RNS) is one of the main causes of end-stage renal disease to children and also a difficult issue in clinic treatment.In recent years,the emergence of new immunosuppresive agents greatly improved the prognosis of children with RNS.In this paper,the application progress of immunosuppresive agents such as cyclophosphamide,ciclosporin,tacrolimus,mycophenolate mofetil,leflunomide and rituximab which were commonly used in recent years to different types of children with RNS are summarized. Key words: Immunosuppressive agents;  Children;  Refractory nephritic syndrome

About this research paper

What this paper is about

Refractory nephrotic syndrome(RNS) is one of the main causes of end-stage renal disease to children and also a difficult issue in clinic treatment.In recent years,the emergence of new immunosuppresive agents greatly improved the prognosis of children with RNS.In this paper,the application progress of immunosuppresive agents such as cyclophosphamide,ciclosporin,tacrolimus,mycophenolate mofetil,leflunomide and rituximab which were commonly used in recent years to different types of children with RNS are summarized. Key words: Immunosuppressive agents;  Children;  Refractory nephritic syndrome

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Refractory nephrotic syndrome(RNS) is one of the main causes of end-stage renal disease to children and also a difficult issue in clinic treatment.In recent years,the emergence of new immunosuppresive agents greatly improved the prognosis of children with RNS.In this paper,the application progress of immunosuppresive agents such as cyclophosphamide,ciclosporin,tacrolimus,mycophenolate mofetil,leflunomide and rituximab which were commonly used in recent years to different types of children with RNS are summarized. Key words: Immunosuppressive agents;  Children;  Refractory nephritic syndrome

Key concepts: Medicine, Rituximab, Nephritic syndrome, Refractory (planetary science), Leflunomide, Nephrotic syndrome, Tacrolimus, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Application progress of immunosuppresive agent in refractory nephritic syndrome in children — Research Paper | ScholarLens